Similar articles

• The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS.

  Mahony BO, Turner A. Mahony BO, et al. Vox Sang. 2010 Apr;98(3 Pt 2):447-50. doi: 10.1111/j.1423-0410.2010.01310.x. Epub 2010 Feb 11. Vox Sang. 2010. PMID: 20158697 No abstract available.
• Applying radio-frequency identification (RFID) technology in transfusion medicine.

  Hohberger C, Davis R, Briggs L, Gutierrez A, Veeramani D. Hohberger C, et al. Biologicals. 2012 May;40(3):209-13. doi: 10.1016/j.biologicals.2011.10.008. Epub 2011 Nov 10. Biologicals. 2012. PMID: 22079476
• Is the gift still good? Examining the politics and regulation of blood safety in the European Union.

  Farrell AM. Farrell AM. Med Law Rev. 2006 Summer;14(2):155-79. doi: 10.1093/medlaw/fwl001. Epub 2006 May 3. Med Law Rev. 2006. PMID: 16831820 No abstract available.
• Implementation of ISBT 128, a quality system, a standardized bar code labeling of blood products worldwide, electronic transfusion pathway: four years of experience in Norway.

  Aandahl GS, Knutsen TR, Nafstad K. Aandahl GS, et al. Transfusion. 2007 Sep;47(9):1674-8. doi: 10.1111/j.1537-2995.2007.01340.x. Transfusion. 2007. PMID: 17725733
• Self-sufficiency, free trade and safety.

  Rautonen J. Rautonen J. Biologicals. 2010 Jan;38(1):97-9. doi: 10.1016/j.biologicals.2009.10.022. Epub 2010 Jan 13. Biologicals. 2010. PMID: 20074979 Review.